GA
Goldstein Advisors’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $496K | Sell |
636
-29
| -4% | -$22.6K | 0.07% | 93 |
|
|
2025
Q1 | $549K | Buy |
665
+38
| +6% | +$31.4K | 0.08% | 87 |
|
|
2024
Q4 | $484K | Sell |
627
-19
| -3% | -$14.7K | 0.07% | 94 |
|
|
2024
Q3 | $572K | Buy |
646
+16
| +3% | +$14.2K | 0.09% | 81 |
|
|
2024
Q2 | $570K | Sell |
630
-21
| -3% | -$19K | 0.1% | 74 |
|
|
2024
Q1 | $506K | Buy |
651
+16
| +3% | +$12.4K | 0.09% | 79 |
|
|
2023
Q4 | $370K | Buy |
635
+72
| +13% | +$42K | 0.06% | 125 |
|
|
2023
Q3 | $302K | Buy |
563
+32
| +6% | +$17.2K | 0.06% | 103 |
|
|
2023
Q2 | $249K | Buy |
+531
| New | +$249K | 0.05% | 120 |
|
|
2023
Q1 | – | Sell |
-603
| Closed | -$221K | – | 166 |
|
|
2022
Q4 | $221K | Buy |
+603
| New | +$221K | 0.05% | 124 |
|